Reference no: EM133872114

Nurses play a critical role in the safe and effective use of medications to treat disorders of the respiratory and gastrointestinal (GI) systems. These systems are frequently affected by chronic illnesses such as asthma, COPD, GERD, and IBS, all of which require targeted pharmacologic interventions. With a diverse range of medication classes available-bronchodilators, anti-inflammatories, proton pump inhibitors, antacids, antiemetics, and laxatives-nurses must be proficient in pharmacokinetics, monitoring parameters, patient teaching, and adverse effect recognition. This discussion explores key drug classes, nursing practices, and safety strategies when managing respiratory and GI medications.

Case Study

Mrs. Helen Dawson, a 67-year-old woman with a history of COPD and GERD, is admitted to the hospital with worsening shortness of breath, nonproductive cough, and abdominal discomfort. She uses a tiotropium inhaler daily, takes albuterol as needed, and recently started omeprazole for her GERD. Her medication list includes lisinopril and furosemide. She reports dizziness and frequent loose stools over the past three days. Her labs reveal mild hypokalemia, and her ABG shows slight respiratory acidosis. Chest auscultation reveals wheezing, and her oxygen saturation is 91% on room air. She states, "Sometimes I skip meals because my stomach burns, and these puffers make me jittery." The provider plans to add guaifenesin, continue omeprazole, and provide ondansetron PRN.

Discussion Prompt

1. Identify the common medications prescribed for respiratory conditions such as COPD and asthma. What are their classes, indications, pharmacokinetics, and potential side effects relevant to Helen's symptoms?

2. Contrast different classes of GI medications used to treat GERD, constipation, and nausea. How do they differ in mechanism of action, monitoring needs, and nursing considerations?

3. Discuss nursing interventions and patient education for clients like Helen who are managing multiple medications affecting both the respiratory and GI systems, with a focus on adherence, adverse reaction monitoring, and lifestyle considerations.